Thompson FDA

Guide to Good Clinical Practice & Module

Your one-stop resource for clinical trial regulations, guidelines and best practices.

See It Live › Free Trial ›
Buy Now

Please enter your desired quantity.


$789.00 Good Clinical Practice Module | Thompson FDA Compliance Expert

$919.00 plus $40 S&H

$919.00 Guide to Good Clinical Practice | Thompson FDA Compliance Expert

Dual (Online + Print)
$1189.00 plus $40 S&H

$1189.00 Guide to Good Clinical Practice & Module | Thompson FDA Compliance Expert

The Guide to Good Clinical Practice is your one-stop resource for clinical trial regulations and guidelines — everything you need to conduct clinical trials more effectively, streamline the process and ensure human subject protection and trial data integrity. This resource is THE most comprehensive and straightforward resource of its kind.

Major Topics Covered

The Guide to Good Clinical Practice provides sponsors, institutional review boards (IRBs), clinical investigators, monitors and study site staff with the information and tools they need to conduct quality clinical trials of new drugs, devices and biologics. From explanations of laws, federal regulations and international harmonization efforts to an analysis of accepted good clinical practices, the Guide helps clinical researchers avoid costly errors and gain faster product approval. The Guide to Good Clinical Practice includes sample checklists for conducting quality assurance audits, FDA forms, industry guidance documents and information sheets, quarterly newsletters, updates, news and analysis on key developments in conducting clinical research, and additional resources.

Guide to Good Clinical Practice brings the very latest clinical trial regulations and guidelines to keep your trials in strict compliance.

You’ll find…

  • Current information on federal agency mandates
  • Questions and answers on meeting FDA, OHRP and international requirements
  • Regulations on obtaining informed consent, recordkeeping, reporting, and research misconduct
  • How-to information for meeting the revised privacy requirements of HIPAA
  • The scientific and legal obligations of sponsors, monitors, investigators, and review boards
  • How to avoid protocol violations, transcription errors and changing study accountability
  • Much more!

Order today – not knowing can be costly!

About Your Subscription

You will receive the two-volume Guide to Good Clinical Practice in print and/or access to the manual online at Based on the delivery method you choose, your annual subscription also includes quarterly print and/or rolling digital updates, news, analysis and more at no additional charge for the 12-month subscription period. Additionally, online subscribers receive access to our FDA Enforcement Letter Database as well as our Clinlaw Database, which provides comprehensive information about laws and regulations governing clinical research for all 50 U.S. states plus the District of Columbia. If you have any questions or would like information about bulk pricing or site licenses, please contact Client Services at 800-677-3789 or by emailing

Authors and Editors

Gary L. Yingling

Gary L. Yingling is a partner with the law firm of Morgan, Lewis & Bockius LLP in Washington, D.C. One of his particular interests has been clinical research/contract research organization/sponsor matters. He served as president of the Food and Drug Law Institute (FDLI) for nine years. He was a recipient of FDLI's 1998 Distinguished Service and Leadership Award, presented annually to honor an outstanding practitioner in food and drug law. He worked at the FDA's Office of the General Counsel for 10 years, first as a trial attorney, and later as associate chief counsel for its Bureau of Veterinary Medicine and the deputy chief counsel for administration. He also was director of over-the-counter drug review in the Bureau of Drugs. In 1974, he received the FDA's Award of Merit, the agency's highest award, for his legal and administrative work on the OTC Review. Prior to joining the FDA, he worked for the National Communicable Disease Center in the Pesticides Program. He received his J.D. from Emory University, an M.S. in pharmacology from Purdue University and a B.S. in pharmacy from the University of North Carolina

Mary Bernadette Ott

Mary Bernadette Ott was a regulatory affairs and quality assurance consultant specializing in establishing in-house good clinical practice auditing programs for sponsors, conducting audits at clinical investigator sites and training sponsors, contract research organizations and clinical investigators on FDA and international good clinical practice requirements. Formerly, she was an FDA field investigator in the agency's Philadelphia District Office and a supervisory investigator in its Boston District Office. She received a B.S. in biology from Chestnut Hill College in Philadelphia.


Select to add to your shopping cart.